Toshihiro Tanaka Selected Research

Toshihiro Tanaka Research Topics

Disease

62	Neoplasms (Cancer) 09/2021 - 01/2002
20	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019 - 10/2004
18	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2007
14	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 06/2009
11	Inflammation (Inflammations) 02/2021 - 12/2003
11	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2007
11	Myocardial Infarction 01/2014 - 12/2002
7	Breast Neoplasms (Breast Cancer) 08/2020 - 03/2004
4	Thrombosis (Thrombus) 11/2021 - 09/2012
4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 05/2021 - 07/2010
4	Adenocarcinoma 01/2021 - 09/2007
4	Infections 01/2021 - 06/2006
4	Carcinoma (Carcinomatosis) 05/2014 - 12/2005
3	Hemorrhage 11/2021 - 01/2003
3	Immunoglobulin G4-Related Disease 02/2021 - 01/2016
3	Ulcer 01/2020 - 01/2010
3	Hypertension (High Blood Pressure) 01/2019 - 06/2010
3	Fever (Fevers) 08/2018 - 02/2003
3	Pain (Aches) 01/2018 - 12/2012
3	Atrial Fibrillation 06/2017 - 04/2014
3	Pemphigus (Pemphigus Vulgaris) 07/2016 - 04/2009
3	Acne Vulgaris 06/2013 - 01/2011
3	Atherosclerosis 06/2010 - 04/2006
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2005 - 03/2002
2	Human Influenza (Influenza) 01/2021 - 07/2009
2	Febrile Neutropenia 09/2020 - 01/2017
2	Lymphoma (Lymphomas) 09/2020 - 11/2012
2	Autoimmune Pancreatitis 08/2020 - 04/2020
2	Chronic Pancreatitis 08/2020 - 04/2020
2	Erythema 01/2020 - 01/2012
2	Liver Neoplasms (Liver Cancer) 02/2019 - 09/2008
2	Long QT Syndrome 01/2019 - 01/2015
2	Pathologic Constriction (Stenosis) 01/2019 - 04/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 02/2009
2	Systemic Scleroderma (Systemic Sclerosis) 12/2018 - 01/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 08/2010

Drug/Important Bio-Agent (IBA)

11	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2007
11	Pharmaceutical PreparationsIBA 01/2018 - 10/2004
10	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2002
8	Ethiodized Oil (Ethiodol)FDA Link 09/2021 - 09/2008
8	Cisplatin (Platino)FDA LinkGeneric 05/2021 - 09/2008
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 12/2010
7	Gemcitabine FDA Link 02/2013 - 09/2007
5	GelatinIBA 08/2021 - 09/2008
5	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 11/2002
5	PowdersIBA 05/2021 - 09/2008
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2016
4	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 01/2005
4	Immunoglobulin G (IgG)IBA 02/2021 - 06/2006
4	CytokinesIBA 08/2020 - 05/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 02/2003
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2019 - 12/2010
4	AntibodiesIBA 08/2017 - 11/2006
4	Monoclonal AntibodiesIBA 08/2017 - 06/2006
4	degradable starch microspheresIBA 03/2017 - 11/2012
4	Prednisolone (Predate)FDA LinkGeneric 08/2016 - 04/2009
4	Lymphotoxin-alpha (Lymphotoxin)IBA 04/2013 - 12/2002
4	Galectin 2 (LGALS2)IBA 03/2009 - 05/2004
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2002
3	SteroidsIBA 01/2020 - 04/2009
3	Amino Acids FDA Link 05/2018 - 01/2005
3	Immunoglobulin A (IgA)IBA 01/2018 - 01/2005
3	AntigensIBA 08/2017 - 11/2006
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2014 - 01/2013
3	Dapsone FDA Link 06/2013 - 01/2011
3	Carcinoembryonic AntigenIBA 03/2009 - 06/2006
2	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 11/2012
2	Interleukin-12 Subunit p35IBA 02/2021 - 08/2020
2	Threonine (L-Threonine)FDA Link 01/2021 - 01/2021
2	EmulsionsIBA 11/2020 - 10/2017
2	Epirubicin (Ellence)FDA LinkGeneric 02/2020 - 10/2017
2	Peptides (Polypeptides)IBA 09/2019 - 12/2002
2	HLA-C Antigens (HLA-C)IBA 09/2019 - 01/2018
2	PlasticsIBA 02/2019 - 01/2005
2	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 11/2015
2	Capecitabine (Xeloda)FDA Link 01/2019 - 01/2017
2	Verapamil (Calan)FDA LinkGeneric 01/2019 - 11/2015
2	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
2	PlatinumIBA 09/2018 - 03/2017
2	SurvivinIBA 07/2018 - 07/2004
2	Caspase 3 (Caspase-3)IBA 07/2018 - 07/2010
2	Leucovorin (Folinic Acid)FDA Link 06/2018 - 01/2013
2	LipidsIBA 03/2018 - 02/2015
2	AutoantigensIBA 01/2018 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 09/2012

Therapy/Procedure

35	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
24	Therapeutics 08/2021 - 03/2004
7	Microspheres (Microsphere) 11/2020 - 04/2014
7	Neoadjuvant Therapy 02/2019 - 11/2011
7	Catheters 06/2016 - 01/2003
5	Pancreaticoduodenectomy 02/2019 - 11/2009
4	Stents 09/2021 - 06/2011
4	Radiotherapy 05/2018 - 08/2007
3	Adjuvant Chemotherapy 09/2018 - 11/2009
3	Pancreatectomy 09/2018 - 04/2012
3	Vascular Access Devices (Arterial Line) 06/2016 - 06/2012
2	Endovascular Aneurysm Repair 04/2022 - 07/2013
2	Secondary Prevention 01/2019 - 01/2014
2	Occlusive Dressings (Occlusive Dressing) 01/2018 - 08/2010
2	Uterine Artery Embolization 01/2018 - 11/2010